ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 163 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $144,000 | -49.1% | 34,987 | 0.0% | 0.00% | – |
| Q3 2016 | $283,000 | -67.7% | 34,987 | -60.6% | 0.00% | -100.0% |
| Q1 2015 | $875,000 | -7.5% | 88,700 | +14.9% | 0.00% | 0.0% |
| Q4 2014 | $946,000 | +129.6% | 77,200 | +86.9% | 0.00% | +100.0% |
| Q3 2014 | $412,000 | -82.1% | 41,300 | -94.1% | 0.00% | -85.7% |
| Q1 2014 | $2,305,000 | +6.0% | 700,600 | +6.9% | 0.01% | +16.7% |
| Q4 2013 | $2,175,000 | +6916.1% | 655,200 | +6358.4% | 0.01% | – |
| Q3 2013 | $31,000 | -62.7% | 10,145 | 0.0% | 0.00% | – |
| Q2 2013 | $83,000 | -72.8% | 10,145 | -73.3% | 0.00% | -100.0% |
| Q4 2012 | $305,000 | – | 38,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |